The global Lateral Flow Assays (LFA) Market  was valued at USD 10.2 billion in 2025 and is projected to grow from USD 10.6 billion in 2026 to USD 17.4 billion by 2033, registering a CAGR of 7.4% from 2026 to 2033. The market is witnessing sustained growth due to the increasing demand for rapid, affordable, and easy-to-use diagnostic solutions across clinical, point-of-care (POC),...